Company Filing History:
Years Active: 2024-2025
Title: Berke Cagkan Toptas: Innovator in Cancer Research
Introduction
Berke Cagkan Toptas is a prominent inventor based in Cambridge, MA (US). He has made significant contributions to the field of cancer research, holding 2 patents that focus on novel cancer-associated antibodies. His work aims to enhance the diagnosis and treatment of various cancers.
Latest Patents
Toptas's latest patents include innovative cancer-associated antibody compositions and methods of use. The first patent discloses novel cancer-associated antibodies that are utilized in the treatment and diagnosis of cancer. The complete polypeptide and nucleic acid consensus sequences of these antibodies are reconstructed in silico. The second patent also relates to cancer-associated antibodies and antigen-binding fragments, which are used in the diagnosis and treatment of cancer or its metastasis. Additionally, this patent introduces a novel chimeric antigen receptor or T cell receptor fusion protein that comprises one or more cancer-associated antigen-binding domains, proving useful for cancer treatment.
Career Highlights
Toptas is currently associated with Absci LLC, where he continues to advance his research in cancer therapies. His innovative approach and dedication to improving cancer treatment options have positioned him as a key figure in the field.
Collaborations
Some of his notable coworkers include Daniele Biasci and Ines De Santiago Domingos De Jesus. Their collaborative efforts contribute to the ongoing research and development of effective cancer treatments.
Conclusion
Berke Cagkan Toptas is a dedicated inventor whose work in cancer-associated antibodies is paving the way for advancements in cancer diagnosis and treatment. His contributions are vital to the ongoing fight against cancer, and his innovative spirit continues to inspire others in the field.